The Trump administration’s Justice Department is seeking to deny relief in a lawsuit aimed at restricting access to mail-order abortion drugs, arguing that an ongoing Food and Drug Administration safety review of mifepristone could take a year or more to complete, potentially stretching into 2027.
In a court filing Monday in the case of Louisiana v. FDA, the DOJ claimed that Louisiana and abortion survivor Rosalie Markezich lack standing and are not suffering ongoing harm from the FDA’s policy allowing the drugs to be mailed without in-person medical oversight.
Read Full Article: https://www.lifenews.com/2026/01/29/trump-admin-it-could-take-another-year-to-review-abortion-pill-safety/
